Aurobindo Pharma receives FDA approval on drugs to treat psychotic conditions
Advertisement
Aurobindo Pharma has received the go-head from USFDA for its drug to treat psychotic conditions. Under the new scheme of things, the company will now have the rights to manufacture and market generic Aripiprazole tablets in the American market.
As further confirmed by the company, the approval to distribute the drug is in the strengths of 2mg, 5mg, 10mg, 15mg, 20mg and 30mg, with Aurobindo reported to be ready for the launch now.
As further confirmed by the company, the approval to distribute the drug is in the strengths of 2mg, 5mg, 10mg, 15mg, 20mg and 30mg, with Aurobindo reported to be ready for the launch now.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.